Rhenman & Partners Asset Management AB
Q3 2026 13F filing
Updated 10 days ago93 disclosed positions worth $902.9M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | J IOVANCE BIOTHERAPEUTICS INC | $37.1M | 2.50M | 4.11% | — |
| 2 | A ASTRAZENECA PLC | $30.3M | 185.0K | 3.35% | — |
| 3 | M MERCK & CO. INC | $30.1M | 206.9K | 3.33% | — |
| 4 | M MEDTRONIC PLC | $29.3M | 340.0K | 3.25% | — |
| 5 | U UNITEDHEALTH GROUP INC | $26.2M | 71.4K | 2.90% | — |
| 6 | V VERTEX PHARMACEUTICALS INC | $25.6M | 48.9K | 2.83% | — |
| 7 | G GILEAD SCIENCES INC | $23.7M | 159.1K | 2.63% | — |
| 8 | E EDWARDS LIFESCIENCES CORP | $23.6M | 273.0K | 2.61% | — |
| 9 | B BIOMARIN PHARMACEUTICAL INC | $23.2M | 386.9K | 2.57% | — |
| 10 | B BIOGEN INC | $21.9M | 97.0K | 2.43% | — |
| 11 | L ELI LILLY & CO | $21.8M | 18.9K | 2.42% | — |
| 12 | I INSMED INC | $21.4M | 187.1K | 2.36% | — |
| 13 | C CVS HEALTH CORP | $18.9M | 220.4K | 2.09% | — |
| 14 | C CENCORA INC | $18.8M | 62.5K | 2.08% | — |
| 15 | A AXSOME THERAPEUTICS INC. | $18M | 97.7K | 2.00% | — |
| 16 | A ABBVIE INC | $16.1M | 61.6K | 1.79% | — |
| 17 | J JAZZ PHARMACEUTICALS PLC | $15.7M | 67.8K | 1.74% | — |
| 18 | J JOHNSON & JOHNSON | $15.5M | 58.5K | 1.72% | — |
| 19 | M MCKESSON CORP | $15.2M | 17.9K | 1.69% | — |
| 20 | D DANAHER CORP DEL | $15.2M | 68.5K | 1.68% | — |
| 21 | C CENTENE CORP DEL | $14.8M | 237.5K | 1.63% | — |
| 22 | R REGENERON PHARMACEUTICALS | $14.7M | 19.3K | 1.62% | — |
| 23 | C CHARLES RIV LABS INTL INC | $13.8M | 46.8K | 1.53% | — |
| 24 | B BOSTON SCIENTIFIC CORP | $13.7M | 315.0K | 1.52% | — |
| 25 | I INTUITIVE SURGICAL INC | $13.6M | 33.5K | 1.51% | — |
| 26 | G GUARDANT HEALTH INC | $13.6M | 76.3K | 1.51% | — |
| 27 | T TENET HEALTHCARE CORP | $13.5M | 52.8K | 1.49% | — |
| 28 | A AGILENT TECHNOLOGIES INC | $13.4M | 78.0K | 1.49% | — |
| 29 | A ALKERMES PLC | $12.3M | 302.6K | 1.36% | — |
| 30 | A ANTERIS TECHNOLOGIES GLOBAL | $12M | 1.54M | 1.32% | — |
| 31 | N NEUROCRINE BIOSCIENCES INC | $11.5M | 81.3K | 1.28% | — |
| 32 | A ALIGNMENT HEALTHCARE INC | $11.3M | 1.38M | 1.25% | — |
| 33 | B BRIGHTSPRING HEALTH SVCS INC | $10.9M | 192.9K | 1.21% | — |
| 34 | L LIVANOVA PLC | $10.7M | 140.0K | 1.19% | — |
| 35 | T THERMO FISHER SCIENTIFIC INC | $10.5M | 15.6K | 1.16% | — |
| 36 | N NURIX THERAPEUTICS INC | $10.4M | 439.5K | 1.15% | — |
| 37 | U UNITED THERAPEUTICS CORP DEL | $10.4M | 19.1K | 1.15% | — |
| 38 | C COOPER COS INC | $10.3M | 181.5K | 1.14% | — |
| 39 | P PROCEPT BIOROBOTICS CORP | $9.7M | 535.0K | 1.08% | — |
| 40 | P PENNANT GROUP INC | $9.2M | 236.5K | 1.02% | — |
| 41 | E ERASCA INC | $8.9M | 608.8K | 0.99% | — |
| 42 | R ROYALTY PHARMA PLC | $8.2M | 141.0K | 0.91% | — |
| 43 | E ENCOMPASS HEALTH CORP | $8.1M | 66.3K | 0.89% | — |
| 44 | M MIRUM PHARMACEUTICALS INC | $7.9M | 91.9K | 0.87% | — |
| 45 | V VERA THERAPEUTICS INC | $7.8M | 242.5K | 0.87% | — |
| 46 | A ARROWHEAD PHARMACEUTICALS IN | $7.4M | 112.5K | 0.82% | — |
| 47 | S SPYRE THERAPEUTICS INC | $7M | 78.6K | 0.78% | — |
| 48 | O OSCAR HEALTH INC | $6.8M | 220.0K | 0.75% | — |
| 49 | C CYTOKINETICS INC | $6.8M | 102.8K | 0.75% | — |
| 50 | S STEVANATO GROUP S P A | $6.6M | 316.8K | 0.74% | — |